Resmed Launches AirTouch F30i Fabric CPAP Mask
Resmed's new AirTouch F30i Comfort full face CPAP mask is now available in the United States, Canada, Australia, and New Zealand.
Tag: ResMed
All
Latest
Resmed Launches AirTouch F30i Fabric CPAP Mask
Resmed’s new AirTouch F30i Comfort full face CPAP mask is now available in the United States, Canada, Australia, and New Zealand.
Read More
Resmed Founder Receives 2026 Horatio Alger Award
Dr. Peter Craig Farrell, founder of Resmed Inc, will receive the Horatio Alger Award.
Read More
FDA Clears Resmed Smart Comfort for CPAP Therapy
Smart Comfort is the first FDA-cleared Ai-enabled medical device that recommends personalized comfort settings to help people with OSA start and stay on CPAP therapy.
Read More
Resmed Launches Sleep Institute
Resmed has launched the Resmed Sleep Institute, a global clinical insights initiative dedicated to advancing the science and understanding of sleep health.
Read More
Resmed Launches NightOwl Home Sleep Test
Resmed’s NightOwl is a disposable home sleep test that uses a fingertip sensor to record up to 10 nights of sleep data and transmitting it to clinicians via the user’s smartphone.
Read More
CPAP Reduces Heart-related Mortality Up to 55%
A worldwide study of over one million patients with sleep apnea provides the strongest evidence to date that CPAP therapy not only alleviates OSA symptoms but can also prolong life.
Read More
Global Sleep Study Reveals the Impact of Poor Sleep
Results from ResMed’s fifth annual Global Sleep Study reveal the toll that poor sleep takes on health, work, and relationships.
Read More
Powering Success in Home Mechanical Ventilation
Home respiratory therapists play a key role in driving the success of patients on home mechanical ventilation.
Read More
ResMed Launches Fabric Nasal CPAP Mask
ResMed has introduced its first fabric CPAP mask, the AirTouch N30i, designed to enhance comfort with breathable, moisture-wicking materials in a tube-up design.
Read More
Vaping Predicted to Have Notable Impact on Europe’s COPD Burden
Research predicts that vaping—in addition to smoking and air pollution—will increase the burden of COPD in Western Europe by 2050, while home NIV is expected to reduce mortality from COPD exacerbations.
Read More
ResMed Launches AirFit F40, Its Smallest Full-Face CPAP Mask
The compact full-face mask is designed to offer the comfort of smaller masks without sacrificing performance.
Read More
ResMed Launches AirCurve 11 Bilevel Devices for Sleep Apnea
The series includes a bilevel PAP device designed for improved compliance and an adaptive servo-ventilation device designed to make therapy feel like the patient’s own breath.
Read More
React Health Names New CEO
React Health appointed former ResMed executive Bill Shoop as its chief executive officer, effective February 1, 2024.
Read More
Report Forecasts Dramatic Rise in COPD Cases Globally by 2050
A new study forecasts a significant rise in COPD cases and reveals specific demographics expected to experience the largest increases.
Read More
ResMed Updates Safety Guidance for CPAP Masks With Magnets
ResMed is updating its guides for all CPAP masks with magnets to inform users about potential magnetic interference when magnets are near certain implants and medical devices in the body.
Read More
ResMed: Magnetic CPAP Masks May Interfere With Certain Medical Devices
ResMed has issued an urgent field safety notice for its CPAP masks with magnets due to potential interference with some implants or certain medical devices.
Read More
ResMed Acquires Somnoware
According to ResMed, the Somnoware platform will remain an open platform to enable pulmonary function testing facilities, sleep labs, and physicians to view results from various testing solutions and help diagnosed patients get on to the treatment they need faster.
Read More
PAP Therapies Linked to Lower Mortality and Enhanced Quality of Life
Medical experts at the American Thoracic Society International Conference unveiled new evidence that demonstrates the benefits of positive airway pressure therapies for patients with sleep apnea.
Read More
UC Davis Health Adds Propeller Health Program for Asthma, COPD Patients
UC Davis Health will integrate Propeller Health’s remote monitoring platform into its own electronic health record (EHR) system in an effort to offer personalized treatment for high-risk patients with asthma and COPD.
Read MoreCOPD and the Benefits of Exercise
Researchers conducted a review of qualitative studies of patients with COPD regarding their experiences with physical activities.
Read More
FDA Grants Fast Track Designation to Apnimed Sleep Apnea Drug Candidate AD109
The US FDA has granted Fast Track designation for Apnimed’s oral pharmacologic AD109 for the treatment of obstructive sleep apnea (OSA).
Read More
As Little as Two Hours of PAP Therapy Has Sleep Benefits
Sleep apnea sufferers can gain health benefits from PAP therapy (positive airway pressure) in as little as two hours per night, according to a study presented at ATS 2022.
Read More
Continued CPAP Use Improves Sleep Apnea Survival by 39%
People with obstructive sleep apnea who continued CPAP therapy were 39% more likely to survive than OSA patients who didn’t, according to data at ERS 2021.
Read More
ResMed Launches AirSense 11 PAP Device
ResMed has launched AirSense 11, the company’s next-generation positive airway pressure device for obstructive sleep apnea in the United States.
Read More